about
Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction.Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages.Primary intestinal lymphangiectasia in an elderly female patient: A case report on a rare cause of secondary immunodeficiency.Cathepsin S inhibition suppresses autoimmune-triggered inflammatory responses in macrophages.Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus.Von Willebrand Factor Interacts with Surface-Bound C1q and Induces Platelet Rolling.Complement activation products in acute heart failure: Potential role in pathophysiology, responses to treatment and impacts on long-term survival.Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohorts.Association of Lectin Pathway Protein Levels and Genetic Variants Early after Injury with Outcomes after Severe Traumatic Brain Injury: A Prospective Cohort Study.Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus.Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in Macrophages.The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury—Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor.The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomographyAutoantibodies Against Albumin in Patients With Systemic Lupus ErythematosusRole of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional studyThe Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus[Abdominal pain and hypertension in a 55-year-old male patient]Anti-C1q autoantibodies are linked to autoimmune thyroid disorders in pregnant womenNo association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus ErythematosusA Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney InjurySusceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritisAnti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic SiteFicolin-3 Deficiency Is Associated with Disease and an Increased Risk of Systemic Lupus ErythematosusAssociation of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosusBinding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in MacrophagesAnti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus
P50
Q37413246-FE3E2D6C-0E05-4869-A66D-9B387B78FA63Q39388473-69AAE3A3-E2F5-470D-9782-EAD93B06C74AQ40109979-9685474B-19CA-47AD-8286-33E0C4AF55FEQ41990067-C020A0DA-9119-45C7-9AB8-23581B681260Q47676874-31277881-A364-43B2-B740-14301785F02FQ48324647-435A5974-05F1-46F9-AC40-69CBA63FE8FBQ50075500-65AFE67B-FFD9-440C-B6C4-6975B1FC036DQ50637234-B4355A9C-5722-4AE9-BE3D-506BD4066BE3Q51014787-24C65350-7BCD-403B-843D-5C6252948512Q52577824-994A6D46-D656-4B8A-8FF1-4ABC6AE03E81Q52886621-907499DE-17F2-49A4-B13A-FD82F043E222Q55106013-439FBEA3-6846-49DD-A538-EBDDAE15CDA1Q57061710-58328935-7063-40AA-9F95-089888F0876EQ58586495-7C786C59-A827-4080-B69E-445C1FE9B0F9Q64078418-DE93718A-66BA-41BB-8BF6-0DB6FE04857BQ89120957-1EB28753-96A4-4FD8-8F22-484C174C8C5BQ89182870-13EC41DF-3CFA-4CC3-9124-2B8F0EB9FCF7Q89234828-0E50FA3D-05F0-47E8-BF2E-93E94063D1CFQ89947833-4A860A14-C283-4441-9A0D-F07289815854Q90327136-515C2917-B92B-404A-8AF1-54DFFCD5E137Q91380393-17548270-47E1-4D9B-A412-0ACF4A62F84CQ91584092-C7507174-1D73-4956-88B1-0FE81D407DAEQ91681420-12246CD5-D724-458D-888F-35C83E37372AQ91846767-4F52B9D3-F42D-4BAB-8990-8417B5EC44E4Q91868632-F5BA8880-331A-4345-B01A-EBC418BD7893Q92390214-795B1612-5C37-4F36-B280-D88EB1905860
P50
description
researcher
@en
wetenschapper
@nl
name
Marten Trendelenburg
@en
Marten Trendelenburg
@nl
type
label
Marten Trendelenburg
@en
Marten Trendelenburg
@nl
prefLabel
Marten Trendelenburg
@en
Marten Trendelenburg
@nl
P108
P31
P496
0000-0001-7036-8386